Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) reported Depreciation & Amortization (CF) of $300,000 for Q3 2026, up 50.0% from $200,000 a year earlier and unchanged from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Aligos Therapeutics' Depreciation & Amortization (CF) came in at $1.18 million, up 26.9% year-over-year; for FY2025, it came in at $930,000, down 9.4% from FY2024.

  • Depreciation & Amortization (CF) has declined for four consecutive years, with a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $1.03 million in FY2024 (-35.8%), $1.6 million in FY2023 (-30.6%), $2.31 million in FY2022 (-23.6%) and $3.02 million in FY2021 (+10.4%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $200,000 in Q1 2025 and a high of $719,000 in Q4 2021.
  • Year over year, Depreciation & Amortization (CF) gained in three of the last eight quarters, with growth averaging 1.8%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2026 (growth of 73.0%); the low point was Q4 2024 (a decline of 43.3%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $300,000 (Q2 2026), $346,000 (Q1 2026) and $230,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.12 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 192.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 1.58 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 300,000.00
Jun 30, 2026 300,000.00
Mar 31, 2026 346,000.00
Dec 31, 2025 230,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 227,000.00
Sep 30, 2024 300,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 300,000.00
Dec 31, 2023 400,000.00
Sep 30, 2023 300,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 500,000.00
Dec 31, 2022 506,000.00
Sep 30, 2022 500,000.00
Jun 30, 2022 600,000.00
Mar 31, 2022 700,000.00
Dec 31, 2021 719,000.00
API Access

Aligos Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALGS&period=max&api_key=YOUR_API_KEY